IL-22 deficiency increases CD4 T cell responses to mucosal immunization.

Area of Science:

• Immunology
• Vaccinology
• Mucosal Immunology

Background:

• Mucosal vaccines are crucial for preventing infectious diseases but require optimization for robust immune responses.
• Mucosal barriers are vital for defense, and cytokines like Interleukin-22 (IL-22) play a role in maintaining their integrity.
• IL-22 promotes epithelial health by increasing proliferation and reducing apoptosis, enhancing barrier function.

Purpose of the Study:

• To investigate the role of IL-22 in T cell responses during mucosal immunization.
• To determine if modulating IL-22 levels can improve vaccine-induced T cell immunity.

Main Methods:

• Utilized a mouse model to compare immune responses in wild-type and IL-22 deficient mice.
• Administered a protein antigen with cholera toxin adjuvant via intrarectal immunization.
• Assessed antigen-specific CD4 T cell responses.

Main Results:

• IL-22 deficient mice exhibited enhanced antigen-specific CD4 T cell responses after intrarectal immunization compared to wild-type controls.
• No significant differences in CD4 T cell responses were observed when mice were immunized systemically with alum-adsorbed antigen.
• These findings indicate IL-22 specifically dampens T cell immunity during mucosal vaccination.

Conclusions:

• IL-22 negatively regulates T cell development during mucosal immunization.
• Transient inhibition of IL-22 during mucosal vaccination is a potential strategy to boost T cell responses.
• This approach could broadly improve the efficacy of existing and novel mucosal vaccine platforms.